Healthnostics, Inc. (OTC PK: HNSO), a medical and biotechnology
analytics company, announced today that its Board of Directors has
approved a repurchase program of the company’s
free-trading shares of common stock. Management is authorized to arrange
repurchasing of up to 100,000,000 shares of stock under the plan from
time to time until December 31, 2008.
Management feels strongly about the company and its growth prospects,
and that the repurchase plan at this time is prudent in its stage of
development and further enhances shareholder value. The repurchase plan
authorizes management, at its discretion, to repurchase the shares in
the open market as permitted by securities laws and other legal
requirements, and is subject to market conditions and other factors.
This press release may contain certain statements that are not
descriptions of historical information, but are forward-looking
statements within the meaning of Section 27A of the Securities Act of
1933 and Section 21E of the Exchange Act of 1934. These forward-looking
statements refer to matters that involve risks and uncertainties. Such
statements reflect management's current views and are based on certain
assumptions. Actual results could differ materially from the assumptions
currently anticipated.
.gif)
